GlobeNewswire 2021-04-20 Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2021
GlobeNewswire 2021-04-09 Genmab and Seagen Announce U.S. FDA Filing Acceptance for Priority Review of Tisotumab Vedotin Biolo...
GlobeNewswire 2021-03-30 Genmab Announces European Marketing Authorization for Kesimpta® (ofatumumab) in Relapsing Multiple S...
GlobeNewswire 2021-02-25 Transactions with shares and linked securities in Genmab A/S made by managerial employees and their ...
GlobeNewswire 2021-02-23 Genmab announces initiation of share buy-back program
GlobeNewswire 2021-02-23 Genmab Publishes 2020 Annual Report
GlobeNewswire 2021-02-22 Genmab Announces Appointment of Tahamtan Ahmadi to Newly Created Position of Chief Medical Officer, ...
GlobeNewswire 2021-02-10 Genmab and Seagen Submit Tisotumab Vedotin Biologics License Application to the U.S. FDA for Patient...
GlobeNewswire 2021-01-29 CHMP Issues Positive Opinion Recommending Ofatumumab in Relapsing Multiple Sclerosis
GlobeNewswire 2021-01-26 Genmab Announces 2020 Net Sales of DARZALEX® (daratumumab)
GlobeNewswire 2021-01-15 Genmab Announces that Janssen has been Granted U.S. FDA Approval for DARZALEX FASPRO® (daratumumab a...
GlobeNewswire 2021-01-13 Genmab Achieves USD 40 Million Milestone in Collaboration with AbbVie
GlobeNewswire 2021-01-04 Genmab Announces Phase 3 Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer
GlobeNewswire 2020-11-24 Genmab Announces Enapotamab Vedotin Update
GlobeNewswire 2020-11-05 Genmab Announces Phase 3 Study Evaluating Epcoritamab in Patients with Relapsed or Refractory Diffus...
GlobeNewswire 2020-11-04 Genmab Announces Financial Results for the First Nine Months of 2020
GlobeNewswire 2020-10-21 Genmab Announces IFM, HOVON and Janssen Achieve Positive Topline Results in Second Part of Phase 3 C...
GlobeNewswire 2020-10-13 Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2020
GlobeNewswire 2020-09-22 Genmab Commences Binding Arbitration of Two Matters Under License Agreement with Janssen
GlobeNewswire 2020-09-21 Genmab and Seattle Genetics Present Data from Tisotumab Vedotin innovaTV 204 Pivotal Trial in Recurr...
GlobeNewswire 2020-08-20 Genmab Announces Janssen Granted U.S. FDA Approval for DARZALEX® (daratumumab) in Combination with C...
GlobeNewswire 2020-08-20 Genmab Announces Plan to Transition Arzerra® (ofatumumab) to an Oncology Access Program for Chronic ...
GlobeNewswire 2020-08-20 U.S. FDA Approves Kesimpta® (ofatumumab) in Relapsing Multiple Sclerosis
GlobeNewswire 2020-08-12 Genmab Announces Financial Results for the First Half of 2020
GlobeNewswire 2020-07-31 Genmab Announces European Myeloma Network and Janssen Achieve Positive Topline Results from Phase 3 ...